Boston, MA
30
Beds
1,295
Inpatient discharges a year
$3B
Net patient revenue a year
38
In-network payers
Dana-Farber Cancer Institute is a 30-bed hospital in Boston, MA. Below you'll find publicly disclosed negotiated rates and facility details, including 38 in-network payers and 263 disclosed rate categories.
The 24 services Dana-Farber Cancer Institute most likely performs, ranked by likely volume and what it is paid. Each service names one insurer. * marks hidden insurer names; A, B and C rank the remaining rates from low to high and reset for each service.
Book a demo to see hidden insurer names, more payer rates, and hospital data, or start a free trial.
CT imaging
CPT 74177
$2,584 - $6,008
from 4 insurers · median $4,908
Common here, based on CMS Medicare volume
X-ray and bone density
CPT 71046
$372 - $1,666
from 3 insurers · median $1,117
Common here, based on CMS Medicare volume
MRI imaging
CPT 70553
$3,932 - $6,008
from 4 insurers · median $4,908
Common here, based on CMS Medicare volume
CT imaging
CPT 71260
$958 - $3,346
from 4 insurers · median $2,621
Common here, based on CMS Medicare volume
CT imaging
CPT 74176
$2,042 - $3,156
from 3 insurers · median $2,980
Common here, based on CMS Medicare volume
CT imaging
CPT 70450
$518 - $1,290
from 4 insurers · median $951
Common here, based on CMS Medicare volume
Cardiology and vascular testing
CPT 93306
$1,789 - $2,875
from 3 insurers · median $1,921
Common here, based on CMS Medicare volume
Mammography
CPT 77067
$353 - $450
from 4 insurers · median $409
Common here, based on CMS Medicare volume
MRI imaging
CPT 74183
$3,941 - $6,008
from 4 insurers · median $4,908
Common here, based on CMS Medicare volume
Ultrasound
CPT 76830
$721 - $1,290
from 4 insurers · median $951
Common here, based on CMS Medicare volume
MRI imaging
CPT 72148
$2,533 - $3,156
from 3 insurers · median $2,980
Common here, based on CMS Medicare volume
X-ray and bone density
CPT 73630
$272 - $1,666
from 3 insurers · median $1,117
Common here, based on CMS Medicare volume
Ultrasound
CPT 76856
$669 - $1,290
from 4 insurers · median $951
Common here, based on CMS Medicare volume
MRI imaging
CPT 70551
$2,980 - $3,170
from 3 insurers · median $3,156
Common here, based on CMS Medicare volume
Nuclear imaging
CPT 78452
$3,367 - $5,854
from 3 insurers · median $4,585
Common here, based on CMS Medicare volume
Ultrasound
CPT 76642
$988 - $1,666
from 3 insurers · median $1,117
Common here, based on CMS Medicare volume
X-ray and bone density
CPT 73610
$379 - $1,666
from 3 insurers · median $1,117
Common here, based on CMS Medicare volume
X-ray and bone density
CPT 73030
$347 - $1,666
from 3 insurers · median $1,117
Common here, based on CMS Medicare volume
Ultrasound
CPT 76705
$581 - $1,290
from 4 insurers · median $951
Common here, based on CMS Medicare volume
Digestive procedures
CPT 43239
$2,027 - $2,506
from 4 insurers · median $2,341
Common here, based on CMS Medicare volume
Orthopedics and pain
CPT 20610
$519 - $6,162
from 4 insurers · median $3,079
Common here, based on CMS Medicare volume
Cardiology and vascular testing
CPT 93971
$488 - $1,290
from 4 insurers · median $951
Common here, based on CMS Medicare volume
Lung function and sleep
CPT 94010
$550 - $4,119
from 4 insurers · median $3,183
Common here, based on CMS Medicare volume
Cardiology and vascular testing
CPT 93970
$1,029 - $3,156
from 3 insurers · median $2,980
Common here, based on CMS Medicare volume
Median rate as a percent of Medicare across the outpatient services above, and how many services sit above or below the same insurer's median at nearby hospitals. * marks hidden insurer names. These table labels track the same insurers across services; the labels on each service card reset.
| Insurer | Services | Median % of Medicare | Above nearby | Below nearby |
|---|---|---|---|---|
| Insurer A* | 24 | 1295% | 13 | 0 |
| Insurer B* | 24 | 1222% | 20 | 0 |
| Insurer C* | 15 | 1208% | 0 | 0 |
| Insurer D* | 22 | 539% | 10 | 0 |
How we chose these services: 0 appear in this hospital's own Medicare claims, 24 are common here based on CMS Medicare volume, and 0 are typical for the service lines it reports to CMS. Rates come from insurer and hospital price transparency files as of October 2026. Rates under a quarter of Medicare or over 20 times Medicare are left out as likely physician-fee rows or file errors. Book a demo to see all 300 CMS shoppable services for Dana-Farber Cancer Institute, or start a free trial.
Acceptance varies by plan and service. Confirm coverage with your insurer or the hospital's billing department.
Doctors and services
Accredited by The Joint Commission
Finances
$3B net patient revenue
Ownership and leadership
Private (not for profit)
The employer identification numbers (EINs) health plans and networks list for Dana-Farber Cancer Institute in the in-network rate files they publish, with the organization NPIs billed under each.
| Tax ID (EIN) | Plans and networks listing it | Organization NPIs |
|---|---|---|
| 04-2263040Dana Farber Cancer Institute | 73Aetna, BCBS Massachusetts, Cigna, United Healthcare (incl Optum, Rocky Mountain, Health Plan of Nevada, Sierra Health), Allied Benefit Systems and 68 more | 1851333686 Dana-Farber Cancer Institute Inc.1225079940 Dana-Farber Cancer Institute Inc.1356973887 Dana-Farber Cancer Institute Inc.and 10 more |
Source: PayerPrice analysis of insurers' Transparency in Coverage in-network files. An EIN can cover several hospitals and clinics in a health system, and insurers sometimes list other organizations' NPIs under it.
450 Brookline Avenue, Boston, MA 02215
6176323000
The Joint Commission (since 2010)
Accreditation
Major
Medical school affiliation
Private (not for profit)
Ownership type
27
Medicare-certified beds
115
Registered nurses (full-time equivalent)
1976
In Medicare since
Source: CMS Provider of Services file, as reported by the hospital and state surveyors.
What Dana-Farber Cancer Institute reported to Medicare in its latest cost report, covering Oct 1, 2024 to Sep 30, 2025.
1,295
Inpatient discharges
Medicare 34%, Medicaid 1%
10,650
Inpatient days
97% of available bed days used
7,660
Employees (full-time equivalent)
50
Interns and residents (full-time equivalent)
Source: CMS cost report (HCRIS) (report 831668). Figures cover the reporting period, which is not always 12 months, and are self-reported.
Inpatient days and discharges Dana-Farber Cancer Institute reported by payer. Medicare and Medicaid include their managed care plans, shown separately below.
| Medicare | Medicaid | Other | Total | |
|---|---|---|---|---|
| Inpatient days | 3,726 | 233 | 6,691 | 10,650 |
| Discharges | 445 | 19 | 831 | 1,295 |
| Average length of stay | 8.4 days | 12.3 days | 8.1 days | 8.2 days |
| Average daily census | 10.2 | 0.6 | 18.3 | 29.2 |
1,371
Medicare Advantage days
720
Medicaid managed care days
84 discharges
| Unit | Beds | Inpatient days | Medicare days | Occupancy |
|---|---|---|---|---|
| Adults & pediatrics | 30 | 10,650 | 3,726 | 97% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheet S-3 Part I.
The comprehensive outpatient service groups (APCs) Dana-Farber Cancer Institute billed Medicare for most in 2024: 1,466 services in all.
| Service group | Services | Patients | Average charges | Average Medicare payment | US average payment |
|---|---|---|---|---|---|
| Level 3 Excision/ Biopsy/ Incision and DrainageAPC 5073 | 1,353 | 1,060 | $17,107 | $2,421 | $2,141 |
| Level 2 Vascular ProceduresAPC 5182 | 44 | 44 | $7,155 | $1,370 | $1,204 |
| Level 2 Excision/ Biopsy/ Incision and DrainageAPC 5072 | 40 | 38 | $4,967 | $1,387 | $1,220 |
| Level 4 Blood Product Exchange and Related ServicesAPC 5244 | 29 | 29 | $250,048 | $56,850 | $56,850 |
Source: CMS Medicare Outpatient Hospitals by Provider and Service (2024 data, released 2026-06-24), comprehensive APCs for traditional Medicare; CMS omits services with fewer than 11 claims. The US average weights every hospital by its services.
ZIP codes with the most Medicare inpatient stays at Dana-Farber Cancer Institute in 2025. Market share is this hospital's part of every hospital's Medicare stays from the ZIP code. Its published Medicare stays went from 26 in 2020 to 37 in 2025.
| ZIP code | Stays | Of this hospital's stays | Days | Charges | Market share |
|---|---|---|---|---|---|
| 02132 | 14 | 38% | 121 | $1.3M | 1% |
| 03867 | 12 | 32% | 67 | $624,927 | 1% |
| 02131 | 11 | 30% | 130 | $1.2M | 1% |
Source: CMS Hospital Service Area file. Shares are of the 37 stays from ZIP codes CMS publishes; it omits ZIP codes with fewer than 11 stays, so market shares count published stays only.
Staff by profession and the rooms and units Dana-Farber Cancer Institute reported at its latest Medicare certification survey (1993). Counts are people, not full-time equivalents.
115
Registered nurses
124
Physicians
35
Resident physicians
1
Physician assistants
13
Pharmacists
7
Respiratory therapists
3
Dietitians
12
Social workers
Source: CMS Provider of Services file.
1,377 clinicians who bill Medicare list Dana-Farber Cancer Institute as a hospital affiliation. Showing 24 of them. Book a demo to see the commercial rates insurers publish for them, or start a free trial.
Jennifer Byer, MD
Medical Oncology Physician
NPI 1336438522
See commercial rates for Jennifer Byer, MDFernanda Wagenheim, MD
Diagnostic Radiology Physician
NPI 1689939886
See commercial rates for Fernanda Wagenheim, MDSarah Eliades, M.D.
Diagnostic Radiology Physician
NPI 1457709875
See commercial rates for Sarah Eliades, M.D.Peter Doubilet, M.D., PHD
Diagnostic Radiology Physician
NPI 1972598811
See commercial rates for Peter Doubilet, M.D., PHDRafael Altieri, M.D.
Diagnostic Radiology Physician
NPI 1295791119
See commercial rates for Rafael Altieri, M.D.Daimon Simmons, M.D., PH.D
Clinical Pathology Physician
NPI 1124456652
See commercial rates for Daimon Simmons, M.D., PH.DJeffrey Potter, M.D.
Diagnostic Radiology Physician
NPI 1073649653
See commercial rates for Jeffrey Potter, M.D.James Strain, M.D.
Body Imaging Physician
NPI 1316030562
See commercial rates for James Strain, M.D.Petr Jarolim, MD PHD
Clinical Pathology/Laboratory Medicine Physician
NPI 1689690588
See commercial rates for Petr Jarolim, MD PHDJeffrey Gusenburg, M.D.
Vascular & Interventional Radiology Physician
NPI 1376864520
See commercial rates for Jeffrey Gusenburg, M.D.Joshua Stuhlfaut, MD
Diagnostic Radiology Physician
NPI 1972594695
See commercial rates for Joshua Stuhlfaut, MDErnest Yeh, MD
Diagnostic Radiology Physician
NPI 1891938569
See commercial rates for Ernest Yeh, MDHenry Su, MD, PHD
Diagnostic Radiology Physician
NPI 1639141575
See commercial rates for Henry Su, MD, PHDJeanna Walsh, MD
Hematology & Oncology Physician
NPI 1922022540
See commercial rates for Jeanna Walsh, MDRoman Klufas, MD
Neuroradiology Physician
NPI 1598744427
See commercial rates for Roman Klufas, MDEssmaeel Abdel-Dayem, MD
Diagnostic Radiology Physician
NPI 1427088335
See commercial rates for Essmaeel Abdel-Dayem, MDSeth Mcclennen, MD
Clinical Cardiac Electrophysiology Physician
NPI 1265419410
See commercial rates for Seth Mcclennen, MDAndras Schaffer, MD
Dermatopathology Physician
NPI 1578626677
See commercial rates for Andras Schaffer, MDMamata Chithriki, MD
Diagnostic Radiology Physician
NPI 1649303603
See commercial rates for Mamata Chithriki, MDMark Hammer, M.D.
Diagnostic Radiology Physician
NPI 1578884003
See commercial rates for Mark Hammer, M.D.Jorge Medina, M.D.
Diagnostic Radiology Physician
NPI 1477520930
See commercial rates for Jorge Medina, M.D.Matthew Desalvo, M.D.
Diagnostic Radiology Physician
NPI 1790124824
See commercial rates for Matthew Desalvo, M.D.Stefanos Parpos, M.D.
Cardiovascular Disease Physician
NPI 1588723712
See commercial rates for Stefanos Parpos, M.D.Brendan Merchant, MD
Internal Medicine Physician
NPI 1952535445
See commercial rates for Brendan Merchant, MDSource: CMS Doctors and Clinicians facility affiliations, released 2026-10-15, with names and specialties from NPPES. Affiliation means the clinician bills Medicare for care at this hospital; it is not employment.
Revenue, expenses and income Dana-Farber Cancer Institute reported to Medicare for Oct 1, 2024 to Sep 30, 2025. Percentages are of net patient revenue.
| Line | Amount | Share |
|---|---|---|
| Gross patient revenue (charges) | $8.5B | 281.5% |
| Inpatient | $150.2M | 5.0% |
| Outpatient | $8.3B | 276.5% |
| Contractual allowances and discounts | -$5.5B | -181.5% |
| Net patient revenue | $3B | 100.0% |
| Operating expenses | -$3.8B | -126.8% |
| Operating income from patient care | -$806.9M | -26.8% |
| Other income | $1.1B | 37.2% |
| Investment income | $214.2M | 7.1% |
| Other | $905.8M | 30.1% |
| Other expenses | $22.4M | 0.7% |
| Net income | $335.5M | 11.1% |
| Line | Amount | Share |
|---|---|---|
| Traditional Medicare | $651.9M | 8.9% |
| Other payers and self-pay | $6.7B | 91.1% |
| Total charges | $7.4B | 100.0% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Traditional Medicare is the program charges on Worksheets D-3 and D Part V; Medicaid is from Worksheet S-10.
Computed from Dana-Farber Cancer Institute's latest cost report.
-26.8%
Operating margin
Operating income from patient care / net patient revenue
8.1%
Total margin
Net income / net patient revenue plus other income
13.3%
EBITDAR margin
Net income before interest, depreciation and leases (Worksheet A-7), / total revenue
25% of expenses
Personnel costs
Salaries, direct-care contract labor and core wage-related costs / operating expenses
5.6%
Return on assets
Net income for a year / total assets
7.5%
Return on equity
Net income for a year / fund balance
0.12
Long-term debt to fund balance
Mortgages, notes and loans / fund balance
1.49
Current ratio
Current assets / current liabilities
0.74
Quick ratio
Cash, temporary investments and net receivables / current liabilities
11 days
Days cash on hand
Cash and temporary investments / daily operating expenses excluding depreciation
36 days
Days in patient receivables
Net patient receivables / daily net patient revenue
55 days
Average payment period
Current liabilities / daily operating expenses excluding depreciation
0.69
Asset turnover
Total revenue for a year / total assets
13.1 years
Average age of plant
Accumulated depreciation / depreciation for a year
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
What Dana-Farber Cancer Institute owned and owed at the end of its reporting period (Sep 2025), across all fund types: $6B in total assets and a $4.5B fund balance.
| Line | Amount | Of total assets |
|---|---|---|
| Cash and temporary investments | $112.6M | 1.9% |
| Patient receivables, net | $296.3M | 5.0% |
| Inventory | $105.9M | 1.8% |
| Total current assets | $827.2M | 13.8% |
| Property and equipment, net of depreciation | $1.1B | 18.2% |
| Investments and other assets | $4.1B | 68.0% |
| Total assets | $6B | 100.0% |
| Current liabilities | $556.1M | 9.3% |
| Long-term debt | $529.8M | 8.9% |
| Total liabilities | $1.5B | 25.2% |
| Fund balance (net assets) | $4.5B | 74.8% |
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Dana-Farber Cancer Institute's full-year cost reports, by fiscal year end. Reports shorter than ten months are left out.
| Fiscal year ending | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|
| Net patient revenue | $1.3B | $1.6B | $1.9B | $2.3B | $2.6B | $3B |
| Operating expenses | $1.9B | $2.2B | $2.5B | $3B | $3.4B | $3.8B |
| Operating margin | -51.8% | -41.4% | -35.1% | -32.4% | -29.2% | -26.8% |
| Net income | $50.8M | $326M | -$11.8M | $407.9M | $256.7M | $335.5M |
| Total assets | $3.9B | $4.5B | $4.3B | $4.7B | $5.3B | $6B |
| Discharges | 1,420 | 1,431 | 1,290 | 1,300 | 1,299 | 1,295 |
| Inpatient days | 9,385 | 10,059 | 9,609 | 10,445 | 10,544 | 10,650 |
| Medicare Advantage days | 789 | 1,126 | 769 | 1,093 | 1,213 | 1,371 |
| Beds | 30 | 30 | 30 | 30 | 30 | 30 |
| Employees (FTE) | 5,307 | 5,590 | 6,013 | 6,754 | 7,294 | 7,660 |
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements.
Each cost center Dana-Farber Cancer Institute reports, largest first. Total cost includes its share of overhead; the cost-to-charge ratio is total cost / charges.
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Drugs charged to patients | $1.1B | $5B | 0.23 | ||
| Clinic | $282.7M | $564.6M | $697M | 0.81 | 60,689 |
| Laboratory | $6.7M | $73M | $491.7M | 0.15 | |
| Radioisotope | $3.7M | $60M | $296.2M | 0.20 | 5,236 |
| Car t-cell immunotherapy | $42.3M | $191.7M | 0.22 | ||
| Blood storing processing & trans. | $9.2M | $29.5M | $53.3M | 0.55 | 990 |
| Radiology-therapeutic | $3.9M | $26.7M | $228.2M | 0.12 | 11,585 |
| Radiology-diagnostic | $8.5M | $20.2M | $19.1M | 1.06 | 10,811 |
| Ct scan | $3.7M | $11.7M | $162.3M | 0.07 | 2,100 |
| Bwh pharmacy | $11.4M | $38M | 0.30 | ||
| Mri | $2.3M | $6.8M | $60.3M | 0.11 | 3,693 |
| Bw blood | $3.1M | $9.4M | 0.33 | ||
| Bw laboratory | $2.4M | $21.8M | 0.11 | ||
| Medical supplies charged to patient | $2.1M | $1.5M | 1.46 | ||
| Respiratory therapy | $859,395 | $1.4M | $5M | 0.28 | |
| Bw radilogy-dx | $1.2M | $4.1M | 0.30 | ||
| Bw clinic | $903,900 | $1.7M | 0.54 | ||
| Bw operating room | $599,546 | $3.2M | 0.19 | ||
| Bw mri | $299,603 | $3.5M | 0.09 | ||
| Bw ct scan | $238,973 | $3.4M | 0.07 | ||
| Bw radiology-therapeuti | $235,636 | $2.2M | 0.11 | ||
| Bw physical therapy | $227,902 | $578,655 | 0.39 | ||
| Electrocardiology | $68,231 | $163,661 | $7.4M | 0.02 | |
| Bw radioisotope | $154,587 | $880,199 | 0.18 | ||
| Bw ekg | $39,981 | $584,951 | 0.07 | ||
| Bw respiratory | $30,782 | $107,100 | 0.29 | ||
| Bwh m&s supplies | $1,054 | $501,788 | 0.00 |
| Department | Salaries | Total cost | Charges | Cost-to-charge | Square feet |
|---|---|---|---|---|---|
| Adults & pediatrics | $20.1M | $15.6M | $58.1M | 0.27 |
| Department | Salaries | Direct cost | Paid hours | Average hourly wage | Square feet |
|---|---|---|---|---|---|
| Pharmacy | $39M | $939.9M | 2,193 | ||
| A&g other | $117.2M | $278.4M | 63,124 | ||
| Employee benefits department | $16.5M | $269M | 5,494 | ||
| Leased bldgs | $119.8M | ||||
| Operation of plant | $14.4M | $47.4M | 50,817 | ||
| A&g patient care | $12.3M | $39.3M | 19,602 | ||
| Longwood center | $27.2M | ||||
| Cap rel costs-mvble equip | $26.2M | ||||
| Nursing administration | $14.6M | $15.5M | 2,133 | ||
| Central services & supply | $901,069 | $15.4M | 601 | ||
| Yawkey building | $14.8M | ||||
| Cap rel costs-bldg & fixt | $13.1M | 363,286 | |||
| Social service | $10.1M | $13.1M | 446 | ||
| I&r services-other prgm costs apprv | $12.5M | ||||
| Maintenance & repairs | $5.5M | $11.5M | 608 | ||
| Smith | $6.5M | ||||
| Housekeeping | $5.8M | 2,082 | |||
| New capital owned buildings | $4.2M | ||||
| Medical records & library | $3.4M | $3.4M | |||
| Jimmy fund | $2.9M | ||||
| Mayer bld | $2.2M | ||||
| I&r services-salary & fringes apprv | $2.1M | ||||
| Dietary | $1.4M | 150 | |||
| Cafeteria | $1.2M | ||||
| Laundry & linen service | $693,125 | ||||
| Shields warren | $546,362 |
Source: CMS cost report (HCRIS, Form 2552-10), report 831668, as submitted. Hospitals report these figures themselves; they are not audited financial statements. Worksheets A, B-1, C Part I and S-3 Part II.
The officers and board members on Dana-Farber Cancer Institute's Medicare enrollment and on the IRS Form 990 filed under its tax ID.
Source: CMS Hospital All Owners (PECOS), the people the hospital lists on its Medicare enrollment; the first 60 of 73 are shown.
| Name | Title |
|---|---|
| William Hahn MD PHD | COO & EVP |
| Michael L Reney | CFO & Assistant Treasurer |
| Melany Duval | SVP & Chief Philanthropy Officer |
| Craig A Bunnell MD MPH MBA | Chief Medical Officer |
| Jennifer Willcox ESQ | Asst Secretary & General Counsel |
| Jeffrey Meyerhardt MD MPH | Chief Clinical Research Officer |
| Maria Megdal | SVP Chief Administrative Officer |
| Kevin Haigis PHD | Chief Scientific Officer |
| Barrett J Rollins MD PHD | Sr. Advisor To President & CEO |
| Benjamin Ebert MD PhD | Trustee, President, & CEO (as Of 10/1/24) |
| Wendy Gettleman | VP Of Facilities Management & Real Estate |
| Sylvia A Bartel RPh MHP | Sr. VP Of Pharmacy & Cpo |
| Patrick McCormick | SVP Hospital Transformation |
| Naomi Lenane | SVP Information Services CIO |
| Joshua Bekenstein | Trustee & Chairman |
| Lori Whelan | Trustee, Treasurer |
| Monica Chandra | Trustee & Secretary |
| Richard Lubin | Trustee & Vice-chairman |
Board members: Afsaneh Beschloss, Alison Jaffe, Amy Berylson, Amy Kyle ESQ, Andrew Janower, Andrew Kaplan, Beth Terrana, Betty Ann Blum, Bradley Lucas, Brian Knez, Christopher J Hadley, Demond Martin, Doug Grip, Elizabeth Clymer, Elizabeth Rappaport, and 49 more on the return.
Source: IRS Form 990 Part VII filed by Dana-Farber Cancer Institute Inc (EIN 04-2263040), via the IRS e-file data. A health system's return can cover several hospitals.
Helipad
Beth Israel Deaconess Medical Center
FAA location ID 36MA, a medical-use heliport at the hospital.
Source: FAA National Airspace System Resource data, cycle 2026-10-01.
About Dana-Farber Cancer Institute's rates and hospital price transparency.
For MRI brain before and after contrast (CPT 70553), published negotiated rates at Dana-Farber Cancer Institute range from $3,932 to $6,008 across 4 insurers. UnitedHealthcare's rate is $4,599. The median at nearby comparable hospitals is $711. What a patient pays depends on their plan's deductible, coinsurance and network status.
For CT abdomen and pelvis with contrast (CPT 74177), published negotiated rates at Dana-Farber Cancer Institute range from $2,584 to $6,008 across 4 insurers. Aetna's rate is $2,584. The median at nearby comparable hospitals is $515. What a patient pays depends on their plan's deductible, coinsurance and network status.
For Screening mammography, bilateral (CPT 77067), published negotiated rates at Dana-Farber Cancer Institute range from $353 to $450 across 4 insurers. Cigna's rate is $450. The median at nearby comparable hospitals is $100. What a patient pays depends on their plan's deductible, coinsurance and network status.
Dana-Farber Cancer Institute reported 1,295 inpatient discharges and 10,650 inpatient days from Oct 1, 2024 to Sep 30, 2025.
Dana-Farber Cancer Institute reported 7,660 full-time-equivalent employees on payroll from Oct 1, 2024 to Sep 30, 2025.
Dana-Farber Cancer Institute reported $3B in net patient revenue on $8.5B of gross charges for Oct 1, 2024 to Sep 30, 2025, an operating margin of -26.8%, and net income of $335.5M.
Dana-Farber Cancer Institute's Medicare enrollment lists Benjamin L Ebert as President And CEO since 2024.
Insurers' price transparency files list Dana-Farber Cancer Institute under employer identification number 04-2263040 (Dana Farber Cancer Institute). 73 health plans and networks list 04-2263040 for it.
1,377 clinicians who bill Medicare list Dana-Farber Cancer Institute as a hospital affiliation in CMS's Doctors and Clinicians data. The largest groups are medical oncology physician (169), diagnostic radiology physician (157), internal medicine physician (134).
Yes. CMS's Provider of Services file lists The Joint Commission as the accrediting organization for Dana-Farber Cancer Institute, effective 2010.
CMS lists 14 services at Dana-Farber Cancer Institute, including Adult Inpatient Psychiatric Care, Clinical Laboratory, Diagnostic Radiology, Dietary Care, Nuclear Medicine, OT (Occupational Therapy).
In CMS's 2025 Hospital Service Area file, the most Medicare inpatient stays at Dana-Farber Cancer Institute came from ZIP codes 02132 (14), 03867 (12), 02131 (11).
Dana-Farber Cancer Institute has 30 beds, including its psychiatric, rehabilitation and other subprovider units, in its latest Medicare cost report. 27 are Medicare-certified beds in CMS's Provider of Services file. Facility type: Short Term Acute Care Hospital.
Dana-Farber Cancer Institute is located at 450 Brookline Avenue, Boston, MA 02215. Its main phone number is 6176323000.
Dana-Farber Cancer Institute's CMS Certification Number (CCN), also called its Medicare provider number, is 220162.
The National Provider Identifier (NPI) on file for Dana-Farber Cancer Institute is 1851333686.
Dana-Farber Cancer Institute lists 38 in-network payers, including Aetna, Ameri Health, Aspirus Health Plan, Avera Health Plans, and is Medicare-certified. Insurance acceptance may vary by plan, so confirm coverage with your insurer or the hospital's billing department.
263 disclosed rate categories. Each shows the payer, category, code type and group with its code range, and contract type, along with how the rate compares with the state average.
Under 45 CFR Part 180, every US hospital must publish a machine-readable file of its standard charges, including gross charges, discounted cash prices and payer-specific negotiated rates, in the CMS template format. PayerPrice can help hospitals publish and maintain these files.
A chargemaster (charge description master, or CDM) is a hospital's master list of billable items, with codes, descriptions and gross charges. A chargemaster review looks at those lines for accuracy and pricing. PayerPrice can help hospitals review their chargemaster; contact us to discuss your needs.
For hospital finance and compliance teams
The data on this page comes from the files hospitals and payers publish. We help hospitals publish theirs correctly, and take a fresh look at their chargemaster.
We turn your chargemaster and payer contracts into the CMS template file, then keep it current as rates change.
{
"description": "MRI of brain (no contrast)",
"code_information": [
{ "code": "611", "type": "RC" },
{ "code": "70551", "type": "CPT" }
],
"standard_charges": [{
"setting": "outpatient",
"minimum": 250,
"maximum": 400,
"gross_charge": 1200,
"discounted_cash": 1080,
"payers_information": [
{
"payer_name": "Platform Health Insurance",
"plan_name": "PPO",
"methodology": "fee schedule",
"standard_charge_dollar": 400
},
{
"payer_name": "Region Health Insurance",
"plan_name": "HMO",
"methodology": "fee schedule",
"standard_charge_dollar": 250
}
]
}]
}Your chargemaster sets the gross charge on every claim, and many payer contracts base payment on it through percent-of-charge, lesser-of and stop-loss terms. We audit it line by line and show how your charges and negotiated rates compare with peer hospitals before your next negotiation.
What a review covers